Medicus Pharma director granted 50,000 stock options
Medicus Pharma Ltd. director Barry Fishman received a grant of stock options representing 50,000 common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Medicus Pharma Ltd. director Barry Fishman received a grant of stock options representing 50,000 common shares. The options have an exercise price of $0.36 per share and expire on June 3, 2031. They were granted on June 3, 2026 and are scheduled to vest quarterly in four equal installments over one year. Following this grant, Fishman holds 50,000 derivative securities directly.
Insider Trade Summary
Grant/Award: 50,000 shares
Grant/Award
1 txn
Insider
FISHMAN BARRY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 50,000 contracts (Direct)
Footnotes (1)
- F1. The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year.
Key Figures
Option grant size: 50,000 options
Exercise price: $0.36 per share
Expiration date: June 3, 2031
+2 more
5 metrics
Option grant size
50,000 options
Underlying 50,000 common shares granted June 3, 2026
Exercise price
$0.36 per share
Strike price for the 50,000 stock options
Expiration date
June 3, 2031
Option term end for Barry Fishman grant
Vesting schedule
4 equal quarterly installments
Over one year from June 3, 2026 grant date
Total derivatives after grant
50,000 derivative securities
Total options held following the reported transaction
Key Terms
Stock Option, grant/award acquisition, derivative securities, vesting, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option (right to buy)""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
grant/award acquisition financial
"transaction_action: "grant/award acquisition""
derivative securities financial
"derivativeTransactionCount for all derivative-type records"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
vesting financial
"The option is scheduled to vest quarterly in four equal installments over one year."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Medicus Pharma (MDCX) report for Barry Fishman?
Medicus Pharma reported a stock option grant to director Barry Fishman for 50,000 underlying common shares. The award was made as compensation, not an open-market trade, and gives him the right to buy shares at a fixed exercise price.
How many stock options did Barry Fishman receive from Medicus Pharma (MDCX)?
Barry Fishman received options over 50,000 common shares. These options represent a new derivative position for him and are scheduled to vest in four equal quarterly installments over one year after the June 3, 2026 grant date.
What is the exercise price and term of Barry Fishman’s Medicus Pharma (MDCX) options?
The options have an exercise price of $0.36 per share and expire on June 3, 2031. This means he can choose to buy up to 50,000 shares at $0.36 until that expiration date, subject to vesting.
How do Barry Fishman’s Medicus Pharma (MDCX) options vest?
The option grant is scheduled to vest quarterly in four equal installments over one year. Starting from the June 3, 2026 grant date, one-quarter of the 50,000 options should vest each quarter, aligning vesting with ongoing board service.
Is Barry Fishman’s Form 4 transaction in Medicus Pharma (MDCX) a stock purchase or sale?
The Form 4 shows an option grant, not a stock purchase or sale. Transaction code A indicates a grant or award, so he acquired derivative securities as compensation rather than buying or selling common shares in the open market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
